NP1192
NP1192 is a potent, selective PROTAC NAT10 degrader that depletes NAT10 protein and inhibits ac4C modification in cancer cells. NP1192 demonstrates dual inhibition of hypoxia-driven glycolysis and immunosuppression via NAT10/HIF-1α/PD-L1 axis disruption, achieving superior antitumor efficacy and synergizing with anti-PD-L1 both in vitro and in vivo. NP1192 can be used for ovarian, cervical, and glioblastoma cancer research. (Blue: CRBN ligand (HY-148834) ; Black: linker; Pink: NAT10 ligand (HY-16706) ) [1].
Product Specifications
CAS Number
[2966791-41-1]
UNSPSC
12352005
Target
HIF/HIF Prolyl-Hydroxylase; Histone Acetyltransferase; PD-1/PD-L1; PROTACs; PTEN
Related Pathways
Epigenetics; Immunology/Inflammation; Metabolic Enzyme/Protease; PI3K/Akt/mTOR; PROTAC
Field of Research
Cancer; Metabolic Disease; Inflammation/Immunology
Smiles
N#CC1=CC=C(C=C1)C2=CSC(N(/N=C3CCCC/3)CCCCCCC(N4CCN(CC4)C5=C6C(N(C(C6=CC=C5)=O)C7CCC(NC7=O)=O)=O)=O)=N2
Molecular Formula
C39H42N8O5S
Molecular Weight
734.87
References & Citations
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-178360/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
